SYNCOMFBSESYNCOM FORMU (I) LTDMinimalNeutral
Announced Thu, 8 Oct, 2026 · 15:08 IST

Quarterly compliance certificate for dematerialization of securities

SYNCOMF · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-5.8%Reaction day
₹25.05
prior close
₹23.65
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-2.8%-3.1% vs market
Pharmaceuticals peers, median of 172sector-2.4%-3.4% vs sector

On the reaction day the stock moved 3.1 pts less than Nifty Microcap 250 and 3.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.4
10m
-0.5
15m
-0.2
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-5.8-2.8-3.1-2.4-3.4
Next day
-7.1-2.5-4.6-2.6-4.5
2d
-7.5-1.7-5.8-2.5-4.9
3d
-10.9-1.5-9.4-2.5-8.4
4d
-10.7-0.8-9.9-2.5-8.2
5d
-13.9-2.4-11.5-3.2-10.8
1w
-13.9-3.4-10.6-4.3-9.6
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Syncom Formulations has submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The certificate, issued by the company's Registrar and Share Transfer Agent Ankit Consultancy, confirms that securities received from depository participants for dematerialization were processed, the certificates were mutilated and cancelled, and the depository's name was substituted as registered owner in the company's member register within 15 days. This is a standard quarterly filing required for companies with dematerialized shares.

Likely market impact

Routine regulatory filing with no material impact on the company, operations, or shareholders.